The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
This series of online workshops aims to share and discuss best practices in induction therapy in kidney transplantation. Selected centres in Italy, the United Kingdom, and France will discuss their approach to induction therapy and present clinical cases for discussion with the audience.
Through interactive lectures and engaging case study discussions, the workshops will highlight the importance of induction treatment for the overall success of transplantation and will provide practical guidance on how to approach specific scenarios.
The third and final workshop in this series, The role of induction in antibody-incompatible (ABO-HLA) kidney transplantation, will be hosted by the Necker Hospital in Paris, France, and will take place on 21 May, 17:00-18:30 CEST.
Assuming that in kidney transplant recipients the “classical” role of induction is to prevent or postpone the occurrence of acute rejection and that, in contrast, in ABO-/HLA-incompatible transplantation the expected role of induction is mainly to prevent acute antibody-mediated rejection which so far has been difficult to ascertain due to the extreme complexity of these situations, the present workshop will try to define the role of induction in ABO-incompatible transplantation and to highlight the complexity of diagnosis in some cases.
This will be summarised in a short presentation together with an introduction of the role of induction in HIR patients. The final part will be devoted to a complex case report outlining how difficult it is to decipher the role of the main induction therapies we rely on.
Moderators
Raj Thuraisingham | London, United Kingdom
Luca Toti | Rome, Italy
Panellists
Carole Burger
Christophe Legendre
Marion Rabant
View the programme and register now to secure your spot!
This workshop is kindly supported by
26 Mar - 26 Mar 2024 | online
26 Oct - 26 Oct 2023 | online
